Skip to main content
CourtGPT logoCourtGPT
Directory
Law
For Attorneys
Blog
AppointmentsSign InSign Up
§ 12-6a-01 — Maryland Law | CourtGPT
  1. Home/
  2. Laws/
  3. Maryland/
  4. Health Occupations - Title 1 - Definitions; General Provisions/
  5. Title 12 - Pharmacists and Pharmacies/
  6. Subtitle 6a - Therapy Management Contracts/
  7. § 12-6a-01
Maryland Legal Code

§ 12-6a-01

Ask AI about this
(a) In this subtitle the following words have the meanings indicated. (b) 'Authorized prescriber' means a licensed physician, licensed podiatrist, or certified advanced practice nurse with prescriptive authority under § 8–508 of this article. (c) 'Group model health maintenance organization' has the meaning stated in § 19–713.6 of the Health – General Article. (d) 'Health maintenance organization' has the meaning stated in § 19–701(g) of the Health – General Article. (e) (1) 'Institutional facility' means a facility other than a nursing home whose primary purpose is to provide a physical environment for patients to obtain inpatient or emergency care. (2) 'Institutional facility' does not include an urgent care facility that is not part of a facility. (f) 'Prescriber–pharmacist agreement' means an agreement between an authorized prescriber and a licensed pharmacist that is disease–state specific and specifies the protocols that may be used. (g) 'Protocol' means a course of treatment predetermined by the authorized prescriber and licensed pharmacist according to generally accepted medical practice for the proper completion of a particular therapeutic or diagnostic intervention.

t predetermined by the authorized prescriber and licensed pharmacist according to generally accepted medical practice for the proper completion of a particular therapeutic or diagnostic intervention. (h) 'Therapy management contract' means a voluntary arrangement that is: (1) Disease–state specific; (2) Agreed on by: (i) One licensed pharmacist and the licensed pharmacist’s designated alternate licensed pharmacists; (ii) One authorized prescriber and alternate designated authorized prescribers involved directly in patient care; and (iii) One patient receiving care from an authorized prescriber and a licensed pharmacist pursuant to a prescriber–pharmacist agreement and protocol under this subtitle; and (3) Related to treatment using drug therapy, laboratory tests, or medical devices, under defined conditions or limitations for the purpose of improving patient outcomes.